Allena Pharmaceuticals, Inc. (27)
Browse by Contract Category
Contracts
-
At the Market Offering Agreement between Allena Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC, dated July 8, 2022
(Filed With SEC on August 15, 2022)
-
Form of Subscription and Investment Representation Agreement dated July 12, 2022
(Filed With SEC on July 12, 2022)
-
Retention Compensation and Amendment to Employment Agreement, dated January 28, 2022, by and between Allena Pharmaceuticals, Inc. and Richard D. Katz, M.D
(Filed With SEC on February 2, 2022)
-
At Market Issuance Sales Agreement, dated December 23, 2021, between Allena Pharmaceuticals, Inc. and B. Riley Securities, Inc
(Filed With SEC on December 23, 2021)
-
At the Market Offering Agreement dated July 8, 2022 by and between Allena Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on July 11, 2022)
-
Form of Securities Purchase Agreement, dated May 3, 2022, by and between Allena Pharmaceuticals, Inc. and certain Purchaser
(Filed With SEC on May 4, 2022)
-
Form of Placement Agent Warrant
(Filed With SEC on May 4, 2022)
-
Form of Common Warrant
(Filed With SEC on May 4, 2022)
-
Retention Compensation and Amendment to Employment Agreement, dated January 28, 2022, by and between Allena Pharmaceuticals, Inc. and Louis Brenner, M.D
(Filed With SEC on February 2, 2022)
-
Form of Securities Purchase Agreement
(Filed With SEC on July 16, 2021)
-
Form of Pre-Funded Common Stock Purchase Warrant
(Filed With SEC on July 16, 2021)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on July 16, 2021)
-
Transition Agreement, dated March 31, 2021, by and between Allena Pharmaceuticals, Inc. and Edward Wholihan
(Filed With SEC on April 2, 2021)
-
At Market Issuance Sales Agreement, dated March 29, 2021, between Allena Pharmaceuticals, Inc. and B. Riley Securities, Inc
(Filed With SEC on March 30, 2021)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on March 11, 2021)
-
Employment Agreement dated January 29, 2021 between Allena Pharmaceuticals, Inc. and Richard Katz
(Filed With SEC on February 2, 2021)
-
Allena Pharmaceuticals, Inc. 2021 Inducement Equity Plan
(Filed With SEC on January 28, 2021)
-
Amended and Restated Underwriting Agreement, dated December 1, 2020, between Allena Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on December 3, 2020)
-
Loan and Security Agreement, dated September 29, 2020 by and among Allena Pharmaceuticals, Inc. and the parties named therein
(Filed With SEC on October 1, 2020)
-
Registration Rights Agreement, dated September 29, 2020 by and among Allena Pharmaceuticals, Inc. and the parties named therein
(Filed With SEC on October 1, 2020)
-
Amended and Restated Underwriting Agreement, dated July 27, 2020, between Allena Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on July 29, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on June 5, 2020)
-
Description of Securities of the Registrant
(Filed With SEC on March 16, 2020)
-
Loan and Security Agreement by and between Allena Pharmaceuticals, Inc. and Pacific Western Bank, dated June 29, 2018, as amended August 1, 2019
(Filed With SEC on November 13, 2019)
-
Form of Securities Purchase Agreement dated as of June 27, 2019 by and between Allena Pharmaceuticals, Inc. and the purchasers signatory thereto
(Filed With SEC on June 28, 2019)
-
Amended and Restated Employment Agreement, dated January 4, 2019 by and between Allena Pharmaceuticals, Inc. and Louis Brenner, M.D
(Filed With SEC on January 4, 2019)
-
Transition Agreement, dated January 4, 2019 by and between Allena Pharmaceuticals, Inc. and Alexey Margolin, Ph.D
(Filed With SEC on January 4, 2019)